ALLO vs DD · rev $22.0K vs P/E 127, rev $12.39B
Allogene Therapeutics Inc (ALLO) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
ALLO currently screens at market cap $258.1M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the ALLO and DD stock pages for the full models.
Not investment advice.